{"id":"W4411429251","doi":"10.1080/10428194.2025.2504719","title":"Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"AbbVie Canada","keywords":"Chemoimmunotherapy; CD20; Rituximab; CHOP; Monoclonal antibody; Vincristine; Cancer research; Lymphoma; Medicine; B cell; Antibody-dependent cell-mediated cytotoxicity; Diffuse large B-cell lymphoma; Antibody; Immunology; Internal medicine; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002310068,0.0003231095,0.000484877,0.0003543122,0.0001034116,0.0003932345,0.0002675963,0.0002348058,0.0006847431],"category_scores_gemma":[0.0001716083,0.0001326358,0.0002296385,0.0002191729,0.0001516226,0.00020913,0.0002973364,0.0003768129,0.0002184455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002882204,"about_ca_system_score_gemma":0.0002017015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000488139,"about_ca_topic_score_gemma":0.001270979,"domain_scores_codex":[0.9997985,0.00004976381,0.00001474877,0.00003555428,0.00004764808,0.00005371229],"domain_scores_gemma":[0.9999462,0.00001089843,0.000009539153,0.00001121745,0.000006509786,0.00001552937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001508537,0.001375212,0.001001326,0.0002090625,0.0001372709,0.0002104279,0.0001071895,0.002811703,0.927299,0.0002803671,0.000323473,0.06473643],"study_design_scores_gemma":[0.0007313026,0.02285114,0.006587165,0.00002431511,0.0003895225,0.0007762917,0.00006654888,0.008304514,0.9490491,0.0001749218,0.01102363,0.00002163136],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925156,0.003687451,0.001761773,0.00005216331,0.00004302096,0.0001206186,0.00005766446,0.00005864739,0.001702958],"genre_scores_gemma":[0.996702,0.001000431,0.001348608,0.00003399409,0.0000146628,0.00006227055,0.00008277918,0.000008962552,0.0007462735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006847431,"threshold_uncertainty_score":0.002290666,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008323771422152333,"score_gpt":0.2714974549198519,"score_spread":0.2631736834976996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}